Nilotinib: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
< | <StructureSection load='' size='350' side='right' scene='Nilotinib/Nilotinib/1' caption='Nilotinib, also known as Tasigna ([[3cs9]])'> | ||
__TOC__ | |||
===Better Known as: Tasigna=== | ===Better Known as: Tasigna=== | ||
* Marketed By: Novartis | * Marketed By: Novartis | ||
| Line 13: | Line 14: | ||
To see <scene name='Dasatinib/Mtot/2'>morphs of the movement</scene> of key structural elements Click: <scene name='Dasatinib/Mdfg/3'>DFG Movement</scene>, <scene name='Dasatinib/Mpl/4'>P-Loop Movement</scene>, & the <scene name='Dasatinib/Mact/1'>Activation Loop Movement</scene>. | To see <scene name='Dasatinib/Mtot/2'>morphs of the movement</scene> of key structural elements Click: <scene name='Dasatinib/Mdfg/3'>DFG Movement</scene>, <scene name='Dasatinib/Mpl/4'>P-Loop Movement</scene>, & the <scene name='Dasatinib/Mact/1'>Activation Loop Movement</scene>. | ||
</StructureSection> | |||
===Pharmacokinetics=== | ===Pharmacokinetics=== | ||
<table style="background: cellspacing="0px" align="" cellpadding="0px" width="50%"> | <table style="background: cellspacing="0px" align="" cellpadding="0px" width="50%"> | ||
| Line 23: | Line 25: | ||
</tr> | </tr> | ||
</table> | </table> | ||
</StructureSection> | |||
===References=== | ===References=== | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ | ||
